Ex vivo assessment of cellular immune function - applications in patient care and clinical studies

Tissue Antigens

Volumn 84, Issue 5, 2014, Pages 439-449

  Lindemann, Monika ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cellular immune function; Enzyme linked immunospot; Lymphocyte transformation test; Mixed leukocyte culture

Indexed keywords

CYTOKINE; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ALLERGY; ALLOIMMUNITY; ALLOMAP ASSAY; ASSAY; CELLULAR IMMUNITY; CLINICAL STUDY; DILUTION; DNA POLYMORPHISM; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO ASSAY; FLOW CYTOMETRY; GRANULOCYTE FUNCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE CELL FUNCTION ASSAY; IMMUNE DEFICIENCY; LIMITING DILUTION ASSAY; LIVER TRANSPLANTATION; LYMPHOCYTE TRANSFORMATION TEST; MEMORY CELL; MIXED LEUKOCYTE CULTURE; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; VACCINATION; HYPERSENSITIVITY; IMMUNOASSAY; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; NEOPLASMS; PHYSIOLOGIC MONITORING; PROCEDURES; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANTIGENS, NEOPLASM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERSENSITIVITY; IMMUNITY, CELLULAR; IMMUNOASSAY; IMMUNOLOGIC DEFICIENCY SYNDROMES; MONITORING, PHYSIOLOGIC; NEOPLASMS; VACCINATION; VIRUS DISEASES;

EID: 84933500795     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12454     Document Type: Review

References (49)

1. Bain B, Vas MR, Lowenstein L. The development of large immature mononuclear cells in mixed leukocyte cultures. Blood 1964: 23: 108-16.
2. Bach F, Hirschhorn K. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 1964: 143: 813-4.
3. Bach FH, Voynow NK. One-way stimulation in mixed leukocyte cultures. Science 1966: 153: 545-7.
4. Bach FH. Transplantation: pairing of donor and recipient. Science 1970: 168: 1170-9.
5. Grosse-Wilde H. Zelluläre Methoden. DGI Technisches Handbuch Histokompatibilität & Immungenetik: Deutsche Gesellschaft für Immungenetik (DGI), 1998:89-97 (www.immungenetik.de/data/tech/d1.pdf).
6. Grosse-Wilde H, Doxiadis I, Brandt H. Definition of HLA-D with HTC. In: Albert ED, Baur MP, Mayr WR, et al., eds. Histocompatibility Testing, Report on the Ninth International Histocompatibility Workshop and Conference Held in Munich, West Germany, May 6-11, 1984 and in Vienna, Austria, May 13-15, 1984. Berlin: Springer Verlag, 1984, 249-64.
7. Reinsmoen NL. A new era for T-cell immune function assays in transplantation. Tissue Antigens 2010: 75: 658-67.
8. Sharrock CE, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990: 11: 281-6.
9. van der Mast BJ, Rischen-Vos J, de Kuiper P, Vaessen LM, van Besouw NM, Weimar W. Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency. Transplantation 2005: 80: 1220-5.
10. McFarland W, Heilman DH. Comparison of lymphocyte transformation and intradermal reactions to tuberculins. Am Rev Respir Dis 1966: 93: 742-8.
11. Stites DP, Folds JD, Schmitz J. Clinical laboratory methods for detection of cellular immunity. In: Stites DP, Terr AI, Parslow TG, eds. Medical Immunology, 9th edn. Stamford: Appleton & Lange, 1997.
12. Belka C, Ottinger H, Kreuzfelder E et al. Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol 1999: 50: 199-204.
13. Lindemann M, Virchow S, Ramann F et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett 2001: 495: 82-6.
14. Baehner RL, Nathan DG. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968: 278: 971-6.
15. Jirapongsananuruk O, Malech HL, Kuhns DB et al. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol 2003: 111: 374-9.
16. Gabler WL, Bullock WW, Creamer HR. Phorbol myristate acetate induction of chemotactic migration of human polymorphonuclear neutrophils. Inflammation 1993: 17: 521-30.
17. Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988: 110: 29-36.
18. Tanguay S, Killion JJ. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res 1994: 13: 259-63.
19. Weston SA, Parish CR. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 1990: 133: 87-97.
20. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994: 171: 131-7.
21. Altman JD, Moss PAH, Goulder PJR et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996: 274: 94-6.
22. Yamani MH, Taylor DO, Haire C, Smedira N, Starling RC. Post-transplant ischemic injury is associated with up-regulated AlloMap gene expression. Clin Transplant 2007: 21: 523-5.
23. Deng MC, Eisen HJ, Mehra MR et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006: 6: 150-60.
24. Lindemann M, Rebmann V, Ottinger HD, Schmolke K, Kreuzfelder E, Grosse-Wilde H. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors. Exp Hematol 2004: 32: 1103-9.
25. Lindemann M, Grosse-Wilde H, Ottinger HD, Peceny R, Beelen DW. G-CSF-induced alteration of in vitro alloreactivity in stem cell donors is predictive for the occurrence of acute GVHD in recipients. Transplantation 2005: 79: 377-8.
26. Lindemann M, Saure C, Klinkenbusch H et al. Alloreactivity in recipients prior to and post living kidney and liver transplantation. Scand J Immunol 2011: 73: 344-5.
27. Lindemann M, Witzke O, Winterhagen T et al. T-cell function after interleukin-2 therapy in HIV-infected patients is correlated with serum cortisol concentrations. AIDS 2004: 18: 2001-7.
28. Lindemann M, Ottinger HD, Elmaagacli AH et al. Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients. Exp Hematol 2006: 34: 1753-8.
29. Lindemann M, Schuett P, Moritz T et al. Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation. Leukemia 2005: 19: 490-2.
30. Barsegian V, Müller SP, Horn PA, Bockisch A, Lindemann M. Lymphocyte function following radioiodine therapy in patients with thyroid carcinoma. Nucl Med (Stuttg) 2011: 50: 195-203.
31. Caillat-Zucman S, Gimenez JJ, Wambergue F et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int 1998: 53: 1626-30.
32. Lindemann M, Barsegian V, Siffert W, Ferencik S, Roggendorf M, Grosse-Wilde H. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination. Virology 2002: 297: 245-52.
33. Zuckerman JN. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol 1996: 50: 283-8.
34. Craven DE, Awdeh ZL, Kunches LM et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med 1986: 105: 356-60.
35. McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997: 50: 8-14.
36. Lindemann M, Barsegian V, Runde V et al. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. Transplantation 2003: 75: 833-8.
37. Schumann A, Lindemann M, Valentin-Gamazo C et al. Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients. Transplantation 2009: 87: 103-11.
38. Schumann A, Fiedler M, Dahmen U, Grosse-Wilde H, Roggendorf M, Lindemann M. Cellular and humoral immune response to a third generation hepatitis B vaccine. J Viral Hepat 2007: 14: 592-8.
39. Krawczyk A, Roggendorf H, Ludwig C et al. Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy. Liver Transpl 2013: 19: 1411-2.
40. Lindemann M, Böhmer J, Zabel M, Grosse-Wilde H. ELISpot: a new tool for the detection of nickel sensitization. Clin Exp Allergy 2003: 33: 992-8.
41. Lindemann M, Rietschel F, Zabel M, Grosse-Wilde H. Detection of chromium allergy by cellular in vitro methods. Clin Exp Allergy 2008: 38: 1468-75.
42. Esser S, Jablonka R, Heinemann FM et al. Detection of abacavir hypersensitivity by ELISpot method. Inflamm Allergy Drug Targets 2012: 11: 227-34.
43. Lindemann M, Witzke O, Lütkes P et al. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Clin Immunol 2006: 120: 342-8.
44. Lalvani A, Pathan AA, McShane H et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001: 163: 824-8.
45. Barsegian V, Mathias KD, Wrighton-Smith P, Grosse-Wilde H, Lindemann M. Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect 2008: 69: 69-76.
46. Lindemann M, Dioury Y, Beckebaum S et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol 2009: 70: 24-8.
47. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004: 170: 59-64.
48. Ferrara G, Losi M, D'Amico R et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006: 367: 1328-34.
49. Manuel O, Humar A, Preiksaitis J et al. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007: 7: 2797-801.